Author:
Liu Xiao-Jun,Wan Zhao-Fei,Zhao Na,Zhang Ya-Ping,Mi Lan,Wang Xin-Hong,Zhou Dong,Wu Yan,Yuan Zu-Yi
Funder
National Natural Science Foundation of China
National Natural Science Fund for Distinguished Young Scholars of China
National Basic Research Program of China"973 project"
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism
Reference42 articles.
1. Aragam KG, Tamhane UU, Kline-Rogers E, Li J, Fox KA, Goodman SG et al (2009) Does simplicity compromise accuracy in ACS risk prediction? A retrospective analysis of the TIMI and GRACE risk scores. PLoS One 4(11):e7947. doi: 10.1371/journal.pone.0007947
2. Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H et al (2012) ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). G Ital Cardiol (Rome) 13(3):171–228. doi: 10.1714/1038.11322
3. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr et al (2013) 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 127(23):e663–e828. doi: 10.1161/CIR.0b013e31828478ac
4. Kang DO, Seo HS, Choi BG, Lee E, Kim JP, Lee SK et al (2015) Absolute change in fasting plasma glucose over 12 months is associated with 2-year and 5-year major adverse cardiovascular events in patients with drug-eluting stent implants. Int J Cardiol 179:146–152. doi: 10.1016/j.ijcard.2014.10.164
5. Lin B, Koibuchi N, Hasegawa Y, Sueta D, Toyama K, Uekawa K et al (2014) Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice. Cardiovasc Diabetol 13(1):148. doi: 10.1186/s12933-014-0148-1
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献